CSIMarket


Biocryst Pharmaceuticals Inc   (BCRX)
Other Ticker:  
 

Biocryst Pharmaceuticals Inc

BCRX's Fundamental analysis








Looking into Biocryst Pharmaceuticals Inc growth rates, revenue grew by 17.42 % in IV. Quarter 2023 from the same quarter a year ago. Ranking at No. 538

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -1.32 %

Biocryst Pharmaceuticals Inc net loss deacreased by in IV. Quarter 2023 year on year, Biocryst Pharmaceuticals Inc net loss increased by -13.71 % in IV. Quarter 2023 year on year,

More on BCRX's Growth


Biocryst Pharmaceuticals Inc
realized net loss in trailing twelve months.

Biocryst Pharmaceuticals Inc realized cash outflow of $ -1.01per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.76.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.28.


More on BCRX's Valuation
 
 Total Debt (Millions $) 303
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ 1,726,104
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) 6.11
 Tangible Book Value (Per Share $) -2.37

Biocryst Pharmaceuticals Inc
realized net loss in trailing twelve months.

Biocryst Pharmaceuticals Inc realized cash outflow of $ -1.01per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 2.76.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.28.


More on BCRX's Valuation

  Market Capitalization (Millions $) 916
  Shares Outstanding (Millions) 192
  Employees 192
  Revenues (TTM) (Millions $) 331
  Net Income (TTM) (Millions $) -227
  Cash Flow (TTM) (Millions $) -194
  Capital Exp. (TTM) (Millions $) -2
  Total Debt (Millions $) 303
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ 1,726,104
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) 6.11
  Tangible Book Value (Per Share $) -2.37

  Market Capitalization (Millions $) 916
  Shares Outstanding (Millions) 192
  Employees 192
  Revenues (TTM) (Millions $) 331
  Net Income (TTM) (Millions $) -227
  Cash Flow (TTM) (Millions $) -194
  Capital Exp. (TTM) (Millions $) -2





  Ratio
   Capital Ratio (MRQ) 3.31
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) -
  Asset Turnover Ratio (TTM) 0.64
  Inventory Turnover Ratio (TTM) 0.16





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com